Ropes & Gray advised Xeris Biopharma Holdings on the transaction. Xeris Biopharma Holdings, Inc. (Nasdaq:XERS) (Xeris), a biopharmaceutical company, announced that it has entered into an exclusive worldwide...
Xeris Biopharma’s Global Collaboration and License Agreement with Beta Bionics
Allorion Therapeutics’ Licensing Agreement with Avenzo Therapeutics
Ropes & Gray advised Allorion Therapeutics on the transaction. Allorion Therapeutics (Allorion) announced it entered into a global licensing agreement with Avenzo Therapeutics Inc. (Avenzo) to develop and...
ImmunoGen’s Collaboration with Takeda
Ropes & Gray represented ImmunoGen in the deal. ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into an exclusive collaboration with Takeda Pharmaceutical Company Limited (TSE:...
Radius Pharmaceuticals’ Royalty Purchase Agreement with DRI Healthcare
Ropes & Gray and Kirkland & Ellis acted as legal advisors to Radius. Cravath, Swaine & Moore acted as legal advisor to DRI Healthcare. Radius Pharmaceuticals,...
Ovid Therapeutics’ Partnership With Healx
Ropes & Gray advised Ovid Therapeutics on the deal. Ovid Therapeutics announced a strategic partnership with U.K.-based Healx, an AI-powered technology company, that granted Healx the...